BETAMETHASONE | N012657 | SCHERING CORP SUB SCHERING PLOUGH CORP
| Trial | Phase | Status | Sponsor | Enrollment | Dates |
|---|---|---|---|---|---|
| N/A | Active | Zichao Zhang | 64 | 2025-06-03 → 2026-10-26 | |
| N/A | Active | First Hospital of China Medical University | 45 | 2025-04-25 → 2026-11-29 | |
| Phase 2/3 | By Invitation | Wake Forest University Health Sciences | 40 | 2024-07-15 → 2027-12 | |
| N/A | Not Yet Recruiting | Assiut University | 54 | 2026-10-10 → 2028-03-01 | |
| N/A | Not Yet Recruiting | Sohag University | 60 | 2026-06-28 → 2027-12-28 | |
| Phase 4 | Not Yet Recruiting | Benha University | 99 | 2026-10 → 2028-02 | |
| Phase 4 | Not Yet Recruiting | Cairo University | 40 | 2026-08-01 → 2027-01 | |
| N/A | Recruiting | Mansoura University | 72 | 2026-01-06 → 2027-02 | |
| N/A | Recruiting | Istanbul University - Cerrahpasa | 42 | 2026-06-30 → 2027-05 | |
| Phase 4 | Recruiting | Baylor College of Medicine | 40 | 2026-05-08 → 2027-12 |
Source: ClinicalTrials.gov. Trials matched by ingredient name.
Total Spending
$1K
Total Claims
34
Beneficiaries
29
Avg Cost/Unit
$8.96
Spending Trend
Source: CMS Medicare Part D Spending by Drug (2024). Shows gross drug cost under Part D.
12 active API suppliers hold Drug Master Files for this ingredient.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
No patent or exclusivity listings for this strength.